The FDA should make more safe drugs available for over-the-counter purchase, starting with albuterol, in order to reduce ...

Shares of Upstream Bio crashed Wednesday after the biotech's asthma drug succeeded in Phase 2 study, but with a more frequent ...

Federal prescription drug platform TrumpRx aims to provide most-favored-nation pricing. Physicians discuss potential impact ...

Upstream Bio, Inc. UPB shares were trading higher during Wednesday’s premarket session following positive results from the ...

The cost profile of single maintenance and reliever therapy, also known as SMART or single-inhaler therapy, was “favorable” ...

Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations Read more at The Business Times.

The Trump administration’s promised direct-to-consumer drug platform TrumpRx has officially gone live, with President Trump ...

Adults with severe asthma who had poor inhaled corticosteroid/long-acting beta agonist adherence in their first year of tezepelumab did not differ from those with better adherence in several clinical ...

Upstream Bio, Inc. downgraded despite strong Verekitug phase 2 asthma results; assess anti-TSLP competition, dosing edge & catalysts. Click for this UPB update.

Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national ...

Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...